|
 Based
on successful collaboration for 4 years, ANSORP
started to plan for developing the research
foundation which could coordinate and support
research activities more effectively with
regard to planning, financial and administrative
support, and communications. A permanent property
of the foundation was endowed by unconditional
grant from LG Chemical, Yuhan Corporation
and Choongwae Pharma Corporation. The Governing
Board of Trustees was composed of 8 members.
A formal proposal to establish ARFID was submitted
to the Ministry of Health and Welfare in Korea
in October 1999 and was approved as of December
8th, 1999.
The Asian-Pacific Research Foundation for
Infectious Diseases (ARFID) was officially
launched as of January 6th, 2000 with the
first Board meeting. ARFID appointed members
of the International Advisory Board to guide
the operations by the foundation. ARFID established
ABB and IDRI in Seoul, Korea to promote the
research activities in the region in 1999.
|
Brief historical landmarks in the establishment
Brief historical landmarks in the establishment
The
Asian-Pacific Research Foundation for Infectious
Diseases (ARFID) was founded to initiate and
support collaborative research on infectious
diseases and antimicrobial agents. It was originally
conceived as an official supporting system for
international research activities by the Asian
Network for Surveillance of Resistant Pathogens
(ANSORP). From ANSORP activities, the process
to establish
This
phase started with the organization of 
Since 1997, ISAAR has been contributing to gather
the relevant data and information on various
issues of antimicrobial resistance and infectious
diseases with regard to the updated epidemiology,
mechanism of resistance, new diagnostic methods,
therapeutic strategies, and preventive measures.
ISAAR became the most representative international
meeting on infectious diseases and antimicrobial
agents/resistance in the Asian-Pacific region.
